Time to Abandon the Three Rs

Submitting to ?refinement, reduction, and replacement? risks the future of animal research

Written byStuart W.G. Derbyshire
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The best hopes to treat or cure any number of diseases all rely on current animal experiments. Like all science, the investigations that scientists perform with animals increase our knowledge of nature and can therefore increase the possibilities for human action, advancing the cause of human freedom. So why do scientists persist in denigrating their own behavior by advocating the three Rs: refinement, reduction, and replacement?

In the United Kingdom, since the passage of the 1986 Animals (Scientific Procedures) Act, researchers must obtain a license from the Home Office, which involves an assessment of the invasiveness of the study and the species used, following the principles of the three Rs. Invariably, licensing will require considerable justification for any procedures that involve distressing the animal, and considerable pressure will be applied for the use of fewer animals, and from further down the phylogenetic tree (such as using rats rather than primates). ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies